×
戻る Agenda
S2 - Regulatory Updates and Implications for Clinical Development
Session Chair(s)
Ling Su, PHD
Research Fellow
Yeehong Business School, China
Jeewon Jeong, PHD
Director
Korean Ministry of Food and Drug Safety (MFDS) , Korea, Republic of
Speaker(s)
Sarah Ibrahim, PHARMD, PHD
FDA, United States
Acting Deputy Center Director for Regulatory Programs
Massimiliano Sarra
European Medicines Agency, Netherlands
Scientific specialist (SNE)
Mizukami Maki
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Clinical Compliance Inspector, Office of Clinical & Non-clinical Compliance II
Xiaoyuan Chen, MD
Tsinghua University, China
Professor
Jooyeon Jung, MPHARM, MS
Ministry of Food and Drug Safety, Korea, Republic of
Division director